Dyck

: 1973 ANZJP Modecate; From the 60's to the 70s'. A new era in the management of schizophrenia. Pioneered by Squibb some 6 years ago, the long-acting fluphenazines have made possible improved patterns of care for the schizophrenic. Moedcate is designed to over-come the obvious limitations of oral medication. Modecate continues to help the psychiatrist and his team to provide the schizophrenic patient with a better chance of life in the community., Fluphenazine, E.R. Squibb & Sons Pty. Ltd., Drawing of a syringe. No real mention of disorder - how this medication is better than oral medication.

: 1973 ANZJP Modecate; Modecate represents a significant advance in anti-psychotic therapy. One injection of Modecate means 3 weeks of controlled therapy - the most potent prophylactic against schizophrenia relapse. Modecate minimises the risk of relapse. A single injection of Modecate provides proven phenothiazine therapy for approximately 3 weeks and eliminates the risk of readmission due to discontinuance of oral medication - the most frequent cause of schizophrenic relapse. Modecate provides benefits to hospital and patient. Within 3 weeks' controlled therapy in a single injection, Modecate saves valuable nursing and hospital time as well as eliminating the need for patient home-nursing care. N.B. the use of Modecate should be restricted as far as possible to physicians experienced in the management of physciatric disorders., Squibb fluphenazine deconate, Squibb.

: 1973 ANZJP Mutabon; When depression and anxiety coincide, dual action Mutabon treats both sides of the emotional problem. On one side amitriptyline hydrochloride for antidepressant action against depression. On the other side perphenazine for tranquiliser action against anxiety/agitation. Three dosage forms Mutabon-A (4/10) - patients with a moderate degree of anxiety or agitation with associated mild depression , Mutabon-D (2/25) - where anxiety and associated depression is moderate or severe and overall severity of the emotional condition is more pronounced, Mutabon-F (4/25) - in severely ill patients with Schizophrenia, Perphenazine-amitriptyline hydrochloride, Schering Corporation USA, Essex Laboratories Pty Ltd.

: 1973 ANZJP Neulactil; When life is disrupted 'Neulactical' puts the pieces back together. The May & Baker tranquilizer for Psychoses and Agression. Safe in long term therapy. No reported incidence of blood dyscrasias and/or Hepatic dysfunction. Very low incidence of neurological side effects. Now available as NHS benefit S.P., May & Baker Ltd., Picture of photograph of family torn up then put back together., Includes dosage info, also mentions conditions such as schizophrenia, paranoia, manic psychoses, major organic psychoses.

: 1973 ANZJP Noveril; Lift the mask of depression with Noveril. For the depressed patient where too much sedation or stimulation is undesirable., Dibenzepin Hydrochloride, Wander Ltd., Sandoz Australia Pty. Ltd. Pharmaceutical Division, Image of aboriginal mask.

: 1973 ANZJP ORAP; The benefits of ORAP pimozide. ORAP has a prolonged action making for an effective once-a-day dosage regime. Drug induced extrapyramidal effects are less intense with ORAP than standard antipsychotic therapy and anti-Parkinsonian medication is not so frequently required with normal therapeutic doses of ORAP. Sedation has not been seen as as significant problem with ORAP. ORAP - new oral antipsychotic for effective maintenance in schizophrenia., Pimozide, Ethnor Pty. Ltd., One white page with orange writing, and one orange page with white writing.

: 1973 ANZJP Ospolot; Maintains balanced control of behavioural disorders associated with temporal lobe dysfunction. Ospolot is the well-known anticonvulsant which is specific in the treatment of behavioural disorders resulting from temporal lobe dysfunction. Unrestricted NHS benefit., Suithiame, Bayer Pharmaceutical Company, Woman's head from about the eyes up. Across her forehead is a tightrope with a man riding a bicycle across it. The man is upside down holding onto one handle bar with one hand the the other is in the air.

: 1973 ANZJP Parnate; Not every road has a turning for many patients, depression can be a one-way street with suicide as its ending. Because of this, anti-depressant therapy must not only be effecitve, but also rapid in its onset of action. Even moderate delays between prescribing and therapeutic effect can have tragic consequences. 'Parnate' acts rapidly; often relieving moderate to severe depression in as little as 1 to 3 days. The patients feels better faster - and the danger of suicide is greatly diminished. This rapid action also means that 'Parnate' gives the physician an early indication of therapeutic effect, allowing psychotherapy to being almost immediately. 'Parnate' - the fast therapeutic response to depression., Tranylcypromine, Smith, Kline and French Laboratories (Australia) Ltd., Sketch of a long, one way street, in black and white. Implies that it should be used in conjunction with psychotherapy.

: 1973 ANZJP Parstelin; Anxiety can be a most depressing condition…Sometimes anxiety and depression aren't clear cut, well defined conditions. Often they co-exist, and a patient presenting with a confusion of symptoms may well be suffering from a mixed anxiety/depression syndrome. In these cases, treatment of one half of the condition will only serve to aggravate the other. 'Parstelin' the combination of 'Parnate' (tranylcypromine) and 'Stelazine' (trifluoperazine) controls both sides of the mixed anxiety/depression syndrome, relieving agitation, mood changes and insomnia, while patients benefit from fast therapeutic response and a convenient, easy to remember b.d. dosage. 'Parstelin' - for rapid control of co-existent depression and anxiety., Trifluoperazine and tranylcypromine., Smith, Kline and French Laboratories (Australia) Ltd., Woman's face in shadows, seems upset. Notes that drug is a combination of Stelazine (trifluoperazine) and Parnate (tranylcypromine)

: 1973 ANZJP Serenace; A return to the family circle for the schizophrenic…Serenace (haloperidol) controls Agitation, Anxiety and Aggression without soporific or sedative effects. Serenace leads the way towards a return to reality. NHS BENEFIT (SP)., Haloperidaol, Searle Australia Pty. Ltd., Show son fishing with father, and mother and baby watching from shore.

: 1973 ANZJP Sinequan; The psychotherapeutic agent of the 70's for the syndrome of the 70's reactive depression. Sinequan…the first new class of broad action psychotherapeutics - indicated for the treatment of reactive depression particularly where anxiety, tension or agitation is a factor. Now with one drug you can safely and effectively treat depression and rely on the anxiolytic action of Sinequan to relieve the problems of anxiety where they co-exist. Sinequan* Dopexin. For the syndrome of the 70's reactive depression., Doxepin, Pfizer Laboratories, Portrait of six different patients, with a quote underneath and a list of symptoms. Two pages.

: 1973 ANZJP Stelazine; Effective management of schizophrenia - a framework of well ordered activities and 'Stelazine'. In the management of schizophrenia…the first thing is to make sure that there is a framework of well ordered activities - a therapeutic environment of constructive management. 'Stelazine' is an nitegral part of this environment. By encouraging in your patient a more alert and receptive state of mind, 'Stelazine' plays a vital role in gaining full benefit from planned activities and therapy., Trifluoperazine, Smith, Kline and French Laboratories (Australia) Limited, Old man painting, paint stroke covers his face, black and white. Says drug is part of larger scheme of therapy.

Main menu